MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

SEPTEMBER 23, 2021

Always consult a physician before attempting alternative therapies. Fortunately, one such man, Levi Barker, provided us with some much-needed insight into what the substance is, how it is used in treatment, and more. Many of us have more in our minds than we need… Veriheal: Can you walk us through a typical iboga treatment?

Treatment 98

Treatment Medicine Research and Development Therapy 98

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. A literature review of existing research suggested that CBD specifically may hold therapeutic potential for the treatment of insomnia.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Veriheal

NOVEMBER 30, 2021

Always consult a physician before attempting alternative therapies. For the first time in over 50 years, a federal grant has been allocated for studying psychedelic treatment. In 2008, he published psychedelic safety guidelines. In 2014, he developed and published the first research on psychedelic treatment of tobacco addiction.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” Rules and Restrictions.

Legislation 98

Legislation Treatment Therapy Conditions 98

Cannabis Law Report

JUNE 12, 2021

She says the treatment did little but left her feeling numb and unable to heal. “The data was showing that psychedelics were providing benefits to people suffering from anxiety, depression, addiction and PTSD. The treatments were carefully dosed and conducted under medical supervision.

Therapy 105

Therapy Treatment Medicine Sleep 105

Cannabis Law Report

SEPTEMBER 23, 2021

This Was the World’s First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction. BIMA was an Open-label safety, tolerability and proof-of-concept study to investigate the role of MDMA-Assisted Psychotherapy in treating patients with alcohol use disorder (AUD). Treatment of AUD rates are low at 16%.

Research and Development 52

Research and Development Therapy Treatment Data 52

Veriheal

JUNE 30, 2023

Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment. Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

DECEMBER 11, 2021

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Medical cannabis can be considered as a treatment for a number of conditions – including chronic pain, epilepsy, and insomnia – when first-line options have failed.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JANUARY 31, 2022

The SAP is a federal program that allows healthcare professionals to apply for access to non-marketed medications that have not yet been approved for sale, when such medications show clinical evidence of safety and efficacy and are intended to treat patients with a severe or life-threatening illness.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Veriheal

OCTOBER 29, 2020

Of that, the American National Institute on Drug Abuse (NIDA) has invested just over $1 billion and has allocated far more money to researching cannabis misuse and the negative effects of consuming cannabis and its compounds as a form of therapy. The data for this graphic was provided by Jim Hudson at Hellth.com. . Canada, and the U.K)

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] More recently, MDMA therapy has inched closer to FDA approval. For the regulated community, this is a trend worth watching.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.

CBD 96

CBD Safety Topical Food 96

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.

THC 105

THC Pets Events Hemp 105

SpeedWeed

MARCH 5, 2021

The investigators then performed an analysis of the data to quantify the relationships between lifetime cannabis use, 12-month cannabis use, and 12-month cannabis use frequency (at least monthly use and less than monthly use) and incidence of hypertension. Subjects in the study consumed cannabis by smoking or via oral cannabis oil extracts.

Blood Pressure 52

Blood Pressure Marijuana Data Therapy 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

OCTOBER 21, 2021

Simon is not alone, one study reviewed online forum posts about cannabis and ADHD and found that 25% of posts indicated therapeutic benefits from this treatment – with statements like “While you are high … you will be able to focus much, much better than you normally would” and “(cannabis) helps me greatly with my ADHD.”

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

Cannabis Law Report

NOVEMBER 22, 2019

MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”.

DEA 66

DEA Clinical Trials THC Research and Development 66

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S. We could potentially develop north of 11,000 drugs that are cannabinoid-based.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

CannaMD

SEPTEMBER 10, 2020

Is it safe to continue cannabis-based therapies during pregnancy? This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Food and Drug Administration clearance of its Investigational New Drug (IND) application for the Phase 2 trial of MYMD-1 as a therapy for delaying aging and prolonging healthy lifespan.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

CannaMD

AUGUST 19, 2020

Unlike THC, CBD has a high margin of safety and is well tolerated pharmacologically even after treatments of up to 1500 mg/day for two weeks in both animals and humans, which suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/pathology and disease severity. .” Our initial data suggest that some C.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission. Dr. James A.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Ezra Parzybok

FEBRUARY 12, 2020

Cannabis shows the promise of another treatment option through CBD and THC delivery to treat PPD in new mothers. Modern medicine has enabled effective medication and therapies to treat PPD and related symptoms. The use of cannabis-based treatments for PPD is still a new area of research. What is Postpartum Depression?

Research and Development 52

Research and Development Sleep Treatment CBD 52

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., For Alzheimer’s patients, CBD is one treatment option that is slowing the progression of that disease.”.

CBD 40

CBD Research and Development Safety Therapy 40

Greencamp

APRIL 23, 2019

For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist. What is multiple sclerosis? Scientific research on cannabis and MS.

Research and Development 94

Research and Development Strains Patients Treatment 94

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

FEBRUARY 14, 2020

However, according to the federal Food, Drug & Cosmetic Act and FDA regulations and guidance, CBD products cannot be marketed as food additives, dietary supplements, or for therapeutic uses and treatment of diseases. Class actions against CBD companies proliferate under federal and state law.

State Laws 59

State Laws Law CBD Food 59